Global Basal Insulin (Long-Acting Insulin) Market Research Report 2020

Global Basal Insulin (Long-Acting Insulin) Market Research Report 2020

Table of Contents
1 Basal Insulin (Long-Acting Insulin) Market Overview
1.1 Product Overview and Scope of Basal Insulin (Long-Acting Insulin)
1.2 Basal Insulin (Long-Acting Insulin) Segment by Type
1.2.1 Global Basal Insulin (Long-Acting Insulin) Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Lantus
1.2.3 Levemir
1.2.4 Tresiba
1.2.5 Toujeo
1.2.6 Basaglar
1.2.7 Biosimilar Glargines
1.3 Basal Insulin (Long-Acting Insulin) Segment by Application
1.3.1 Basal Insulin (Long-Acting Insulin) Sales Comparison by Application: 2020 VS 2026
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Global Basal Insulin (Long-Acting Insulin) Market Size Estimates and Forecasts
1.4.1 Global Basal Insulin (Long-Acting Insulin) Revenue 2015-2026
1.4.2 Global Basal Insulin (Long-Acting Insulin) Sales 2015-2026
1.4.3 Basal Insulin (Long-Acting Insulin) Market Size by Region: 2020 Versus 2026
1.5 Basal Insulin (Long-Acting Insulin) Industry
1.6 Basal Insulin (Long-Acting Insulin) Market Trends
2 Global Basal Insulin (Long-Acting Insulin) Market Competition by Manufacturers
2.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Manufacturers (2015-2020)
2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Share by Manufacturers (2015-2020)
2.3 Global Basal Insulin (Long-Acting Insulin) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Basal Insulin (Long-Acting Insulin) Manufacturing Sites, Area Served, Product Type
2.5 Basal Insulin (Long-Acting Insulin) Market Competitive Situation and Trends
2.5.1 Basal Insulin (Long-Acting Insulin) Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Basal Insulin (Long-Acting Insulin) Players (Opinion Leaders)
3 Basal Insulin (Long-Acting Insulin) Retrospective Market Scenario by Region
3.1 Global Basal Insulin (Long-Acting Insulin) Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Basal Insulin (Long-Acting Insulin) Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.3.1 North America Basal Insulin (Long-Acting Insulin) Sales by Country
3.3.2 North America Basal Insulin (Long-Acting Insulin) Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.4.1 Europe Basal Insulin (Long-Acting Insulin) Sales by Country
3.4.2 Europe Basal Insulin (Long-Acting Insulin) Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Region
3.5.1 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region
3.5.2 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.6.1 Latin America Basal Insulin (Long-Acting Insulin) Sales by Country
3.6.2 Latin America Basal Insulin (Long-Acting Insulin) Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.7.1 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country
3.7.2 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Basal Insulin (Long-Acting Insulin) Historic Market Analysis by Type
4.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2015-2020)
4.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2015-2020)
4.3 Global Basal Insulin (Long-Acting Insulin) Price Market Share by Type (2015-2020)
4.4 Global Basal Insulin (Long-Acting Insulin) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Basal Insulin (Long-Acting Insulin) Historic Market Analysis by Application
5.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2015-2020)
5.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2015-2020)
5.3 Global Basal Insulin (Long-Acting Insulin) Price by Application (2015-2020)
6 Company Profiles and Key Figures in Basal Insulin (Long-Acting Insulin) Business
6.1 Novo Nordisk
6.1.1 Corporation Information
6.1.2 Novo Nordisk Description, Business Overview and Total Revenue
6.1.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Novo Nordisk Products Offered
6.1.5 Novo Nordisk Recent Development
6.2 Sanofi Aventis
6.2.1 Sanofi Aventis Corporation Information
6.2.2 Sanofi Aventis Description, Business Overview and Total Revenue
6.2.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Sanofi Aventis Products Offered
6.2.5 Sanofi Aventis Recent Development
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description, Business Overview and Total Revenue
6.3.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Eli Lilly Products Offered
6.3.5 Eli Lilly Recent Development
6.4 Biocon
6.4.1 Biocon Corporation Information
6.4.2 Biocon Description, Business Overview and Total Revenue
6.4.3 Biocon Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Biocon Products Offered
6.4.5 Biocon Recent Development
6.5 Julphar
6.5.1 Julphar Corporation Information
6.5.2 Julphar Description, Business Overview and Total Revenue
6.5.3 Julphar Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Julphar Products Offered
6.5.5 Julphar Recent Development
6.6 Exir
6.6.1 Exir Corporation Information
6.6.2 Exir Description, Business Overview and Total Revenue
6.6.3 Exir Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Exir Products Offered
6.6.5 Exir Recent Development
6.7 Sedico
6.6.1 Sedico Corporation Information
6.6.2 Sedico Description, Business Overview and Total Revenue
6.6.3 Sedico Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sedico Products Offered
6.7.5 Sedico Recent Development
6.8 Wockhardt
6.8.1 Wockhardt Corporation Information
6.8.2 Wockhardt Description, Business Overview and Total Revenue
6.8.3 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Wockhardt Products Offered
6.8.5 Wockhardt Recent Development
7 Basal Insulin (Long-Acting Insulin) Manufacturing Cost Analysis
7.1 Basal Insulin (Long-Acting Insulin) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Basal Insulin (Long-Acting Insulin)
7.4 Basal Insulin (Long-Acting Insulin) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Basal Insulin (Long-Acting Insulin) Distributors List
8.3 Basal Insulin (Long-Acting Insulin) Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Basal Insulin (Long-Acting Insulin) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Basal Insulin (Long-Acting Insulin) by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Basal Insulin (Long-Acting Insulin) by Type (2021-2026)
10.2 Basal Insulin (Long-Acting Insulin) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Basal Insulin (Long-Acting Insulin) by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Basal Insulin (Long-Acting Insulin) by Application (2021-2026)
10.3 Basal Insulin (Long-Acting Insulin) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Basal Insulin (Long-Acting Insulin) by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Basal Insulin (Long-Acting Insulin) by Region (2021-2026)
10.4 North America Basal Insulin (Long-Acting Insulin) Estimates and Projections (2021-2026)
10.5 Europe Basal Insulin (Long-Acting Insulin) Estimates and Projections (2021-2026)
10.6 Asia Pacific Basal Insulin (Long-Acting Insulin) Estimates and Projections (2021-2026)
10.7 Latin America Basal Insulin (Long-Acting Insulin) Estimates and Projections (2021-2026)
10.8 Middle East and Africa Basal Insulin (Long-Acting Insulin) Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Basal Insulin (Long-Acting Insulin) Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Basal Insulin (Long-Acting Insulin) Manufacturers Covered in This Study
Table 5. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Basal Insulin (Long-Acting Insulin) Sales Share by Manufacturers (2015-2020)
Table 7. Global Basal Insulin (Long-Acting Insulin) Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Basal Insulin (Long-Acting Insulin) Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Basal Insulin (Long-Acting Insulin) Sales Sites and Area Served
Table 11. Manufacturers Basal Insulin (Long-Acting Insulin) Product Types
Table 12. Global Basal Insulin (Long-Acting Insulin) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Basal Insulin (Long-Acting Insulin) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Basal Insulin (Long-Acting Insulin) as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Basal Insulin (Long-Acting Insulin) Players
Table 16. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Region (2015-2020)
Table 17. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2015-2020)
Table 18. Global Basal Insulin (Long-Acting Insulin) Revenue (Million US$) by Region (2015-2020)
Table 19. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2015-2020)
Table 20. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2015-2020) (K Units)
Table 21. North America Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2015-2020)
Table 22. North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2015-2020)
Table 24. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2015-2020) (K Units)
Table 25. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2015-2020)
Table 26. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2015-2020)
Table 32. Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2015-2020) (K Units)
Table 33. Latin America Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2015-2020)
Table 34. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2015-2020)
Table 40. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Type (2015-2020)
Table 41. Global Basal Insulin (Long-Acting Insulin) Sales Share by Type (2015-2020)
Table 42. Global Basal Insulin (Long-Acting Insulin) Revenue (Million US$) by Type (2015-2020)
Table 43. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Type (2015-2020)
Table 44. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Type (2015-2020)
Table 45. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Application (2015-2020)
Table 46. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2015-2020)
Table 47. Global Basal Insulin (Long-Acting Insulin) Sales Growth Rate by Application (2015-2020)
Table 48. Novo Nordisk Basal Insulin (Long-Acting Insulin) Corporation Information
Table 49. Novo Nordisk Description and Business Overview
Table 50. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 51. Novo Nordisk Main Product
Table 52. Novo Nordisk Recent Development
Table 53. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Corporation Information
Table 54. Sanofi Aventis Corporation Information
Table 55. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Sanofi Aventis Main Product
Table 57. Sanofi Aventis Recent Development
Table 58. Eli Lilly Basal Insulin (Long-Acting Insulin) Corporation Information
Table 59. Eli Lilly Corporation Information
Table 60. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Eli Lilly Main Product
Table 62. Eli Lilly Recent Development
Table 63. Biocon Basal Insulin (Long-Acting Insulin) Corporation Information
Table 64. Biocon Corporation Information
Table 65. Biocon Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Biocon Main Product
Table 67. Biocon Recent Development
Table 68. Julphar Basal Insulin (Long-Acting Insulin) Corporation Information
Table 69. Julphar Corporation Information
Table 70. Julphar Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Julphar Main Product
Table 72. Julphar Recent Development
Table 73. Exir Basal Insulin (Long-Acting Insulin) Corporation Information
Table 74. Exir Corporation Information
Table 75. Exir Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Exir Main Product
Table 77. Exir Recent Development
Table 78. Sedico Basal Insulin (Long-Acting Insulin) Corporation Information
Table 79. Sedico Corporation Information
Table 80. Sedico Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Sedico Main Product
Table 82. Sedico Recent Development
Table 83. Wockhardt Basal Insulin (Long-Acting Insulin) Corporation Information
Table 84. Wockhardt Corporation Information
Table 85. Wockhardt Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Wockhardt Main Product
Table 87. Wockhardt Recent Development
Table 88. Sales Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Basal Insulin (Long-Acting Insulin) Distributors List
Table 91. Basal Insulin (Long-Acting Insulin) Customers List
Table 92. Market Key Trends
Table 93. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 94. Key Challenges
Table 95. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) Forecast by Type (2021-2026)
Table 96. Global Basal Insulin (Long-Acting Insulin) Sales Market Share Forecast by Type (2021-2026)
Table 97. Global Basal Insulin (Long-Acting Insulin) Revenue (Million US$) Forecast by Type (2021-2026)
Table 98. Global Basal Insulin (Long-Acting Insulin) Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 99. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) Forecast by Application (2021-2026)
Table 100. Global Basal Insulin (Long-Acting Insulin) Revenue (Million US$) Forecast by Application (2021-2026)
Table 101. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) Forecast by Region (2021-2026)
Table 102. Global Basal Insulin (Long-Acting Insulin) Sales Market Share Forecast by Region (2021-2026)
Table 103. Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 104. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share Forecast by Region (2021-2026)
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Basal Insulin (Long-Acting Insulin)
Figure 2. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type: 2020 VS 2026
Figure 3. Lantus Product Picture
Figure 4. Levemir Product Picture
Figure 5. Tresiba Product Picture
Figure 6. Toujeo Product Picture
Figure 7. Basaglar Product Picture
Figure 8. Biosimilar Glargines Product Picture
Figure 9. Global Basal Insulin (Long-Acting Insulin) Consumption Market Share by Application: 2020 VS 2026
Figure 10. Type 1 Diabetes
Figure 11. Type 2 Diabetes
Figure 12. Global Basal Insulin (Long-Acting Insulin) Market Size 2015-2026 (US$ Million)
Figure 13. Global Basal Insulin (Long-Acting Insulin) Sales Capacity (K Units) (2015-2026)
Figure 14. Global Basal Insulin (Long-Acting Insulin) Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Basal Insulin (Long-Acting Insulin) Sales Share by Manufacturers in 2020
Figure 16. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Basal Insulin (Long-Acting Insulin) Revenue in 2019
Figure 18. Basal Insulin (Long-Acting Insulin) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2015-2020)
Figure 20. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region in 2019
Figure 21. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2015-2020)
Figure 22. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region in 2019
Figure 23. North America Basal Insulin (Long-Acting Insulin) Sales Market Share by Country in 2019
Figure 24. North America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country in 2019
Figure 25. U.S. Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 26. U.S. Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 28. Canada Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Country in 2019
Figure 30. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country in 2019
Figure 31. Germany Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 32. Germany Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 34. France Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.K. Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 38. Italy Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 40. Russia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share by Region in 2019
Figure 42. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region in 2019
Figure 43. China Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 44. China Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 46. Japan Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 48. South Korea Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 50. India Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 52. Australia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 54. Taiwan Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 56. Indonesia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 58. Thailand Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 60. Malaysia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 62. Philippines Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 64. Vietnam Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Basal Insulin (Long-Acting Insulin) Sales Market Share by Country in 2019
Figure 66. Latin America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country in 2019
Figure 67. Mexico Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 68. Mexico Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 70. Brazil Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country in 2019
Figure 75. Turkey Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 76. Turkey Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 78. Saudi Arabia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. U.A.E Basal Insulin (Long-Acting Insulin) Sales Growth Rate (2015-2020) (K Units)
Figure 80. U.A.E Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Basal Insulin (Long-Acting Insulin) by Type (2015-2020)
Figure 82. Sales Market Share of Basal Insulin (Long-Acting Insulin) by Type in 2019
Figure 83. Revenue Share of Basal Insulin (Long-Acting Insulin) by Type (2015-2020)
Figure 84. Revenue Market Share of Basal Insulin (Long-Acting Insulin) by Type in 2019
Figure 85. Global Basal Insulin (Long-Acting Insulin) Sales Growth by Type (2015-2020) (K Units)
Figure 86. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2015-2020)
Figure 87. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application in 2019
Figure 88. Global Revenue Share of Basal Insulin (Long-Acting Insulin) by Application (2015-2020)
Figure 89. Global Revenue Share of Basal Insulin (Long-Acting Insulin) by Application in 2020
Figure 90. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Sanofi Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Julphar Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Exir Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Sedico Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of Basal Insulin (Long-Acting Insulin)
Figure 100. Manufacturing Process Analysis of Basal Insulin (Long-Acting Insulin)
Figure 101. Basal Insulin (Long-Acting Insulin) Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America Basal Insulin (Long-Acting Insulin) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. North America Basal Insulin (Long-Acting Insulin) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Basal Insulin (Long-Acting Insulin) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Basal Insulin (Long-Acting Insulin) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Basal Insulin (Long-Acting Insulin) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Basal Insulin (Long-Acting Insulin) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs